Merck & Co Inc (NYSE:MRK)
| 110.05 Delayed Data As of Dec 02 |  +0.25 / +0.23%Today’s Change | 71.50 Today|||52-Week Range 110.98 | +43.59% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 109.80 |
| Today’s open | 108.90 |
| Day’s range | 108.73 - 110.09 |
| Volume | 6,943,575 |
| Average volume (3 months) | 8,864,289 |
| Market cap | $279.0B |
Data as of 4:00pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | +84.65% |
| Earnings growth (this year) | +22.72% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +1.86% |
| P/E ratio | 18.2 |
| Price/Sales | 3.98 |
| Price/Book | 7.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.18 | -0.36% |
| ABBVAbbVie | +2.00 | +1.24% |
| NVONovo Nordisk | +0.75 | +0.59% |
| AZNAstraZeneca | +0.12 | +0.18% |
Data as of 4:00pm ET, 12/02/2022
Financials
| Next reporting date | February 2, 2023 |
| EPS forecast (this quarter) | $1.53 |
| Annual revenue (last year) | $48.9B |
| Annual profit (last year) | $13.0B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
